Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001027978 | SCV002020208 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2020-07-28 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV001027978 | SCV005438871 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | criteria provided, single submitter | clinical testing | The observed stop gained c.370C>T p.Arg124Ter variant in OXCT1 gene has been reported previously in individuals affected with Succinyl-CoA:3-oxoacid CoA transferase SCOT deficiency Grünert et al., 2021. The p.Arg124Ter variant is absent in gnomAD Exomes. This variant has been submitted to the ClinVar database as Likely Pathogenic. Computational evidence MutationTaster - Disease causing predicts damaging effect on protein structure and function for this variant. The nucleotide change c.370C>T in OXCT1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal p.Arg124Ter in the OXCT1 gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. | |
Biochemical Molecular Genetic Laboratory, |
RCV001027978 | SCV001190726 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2020-02-05 | no assertion criteria provided | clinical testing |